# ALGENSCRIBE SAS

> Genome editing for health

Business model and tags: Pharma & life sciences, Has in-house R&D

## About ALGENSCRIBE SAS

Developing patented genome editing tools for gene therapy, cell therapy, oncology, and bioproduction to improve human health.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1–10 employees
- **Headquarters**: Nice, Provence-Alpes-Côte d'Azur, France
- **Founded**: 2022
- **Revenue**: €2.5M – €19.6M (Tamtam estimate)
- **SIREN**: [922650718](https://annuaire-entreprises.data.gouv.fr/entreprise/922650718)
- **Website**: [algenscribe.com](https://www.algenscribe.com/)
- **LinkedIn**: [linkedin.com/company/algenscribe](https://www.linkedin.com/company/algenscribe)

## ALGENSCRIBE SAS at a glance

ALGENSCRIBE SAS is a company in the Biotechnology Research industry, headquartered in Nice, Provence-Alpes-Côte d'Azur, France.

ALGENSCRIBE SAS was founded in 2022.

ALGENSCRIBE SAS has 1–10 employees.

ALGENSCRIBE SAS's revenue is €2.5M – €19.6M (Tamtam estimate).

ALGENSCRIBE SAS's SIREN number is 922650718.

## Frequently asked questions about ALGENSCRIBE SAS

### What is ALGENSCRIBE SAS's revenue?

Tamtam estimates ALGENSCRIBE SAS's annual revenue at €2.5M – €19.6M.

### How many employees does ALGENSCRIBE SAS have?

ALGENSCRIBE SAS has 1–10 employees.

### Where is ALGENSCRIBE SAS headquartered?

ALGENSCRIBE SAS is headquartered in Nice, Provence-Alpes-Côte d'Azur, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/algenscribe-sas